Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Notified -

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest

Avid Bioservices to Report Financial Results for Third

TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics

Alvotech Announces Webcast of 2022 Full Year Financial

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar

Alvotech enters into commercialization agreement with

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area,